{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:49:58Z","timestamp":1792586998075,"version":"4.5.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec \u2013 Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Biobank","award":["48839"],"award-info":[{"award-number":["48839"]}]},{"name":"UK Biobank","award":["66222"],"award-info":[{"award-number":["66222"]}]},{"name":"Toronto General Hospital Foundation"},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","award":["201909PJ9 and 202003PJT"],"award-info":[{"award-number":["201909PJ9 and 202003PJT"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019217","name":"Institut de valorisation des donn\u00e9es","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019217","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009268","name":"Alport Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Glomerular hematuria has varied causes but can have a genetic basis, including Alport syndrome and IgA nephropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>\n                      We used summary statistics to identify genetic variants associated with hematuria in White British UK Biobank participants. Individuals with glomerular hematuria were enriched by excluding participants with genitourinary conditions. A strongly associated locus on chromosome 2 (\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      -\n                      <jats:italic toggle=\"yes\">COL4A3<\/jats:italic>\n                      ) was identified. The region was reimputed using the Trans-Omics for Precision Medicine Program followed by sequential rounds of regional conditional analysis, conditioning on previous genetic signals. Similarly, we applied conditional analysis to identify independent variants in the MHC region on chromosome 6 using imputed\n                      <jats:italic toggle=\"yes\">HLA<\/jats:italic>\n                      haplotypes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 16,866 hematuria cases and 391,420 controls were included. Cases had higher urinary albumin-creatinine compared with controls (women: 13.01 mg\/g [8.05\u201321.33] versus 12.12 mg\/g [7.61\u201319.29];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001; men: 8.85 mg\/g [5.66\u201316.19] versus 7.52 mg\/g [5.04\u201312.39];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001) and lower eGFR (women: 88\u00b114 versus 90\u00b113 ml\/min per 1.72 m\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001; men: 87\u00b115 versus 90\u00b113 ml\/min per 1.72 m\n                      <jats:sup>2<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001), supporting enrichment of glomerular hematuria. Variants at six loci (\n                      <jats:italic toggle=\"yes\">PDPN<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">COL4A4-COL4A3<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">HLA-B<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">SORL1<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">PLLP<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">TGFB1<\/jats:italic>\n                      ) met genome-wide significance (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;5E-8). At chromosome 2,\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      p.Ser969X (rs35138315; minor allele frequency=0.00035;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;7.95E-35; odds ratio, 87.3; 95% confidence interval, 47.9 to 159.0) had the most significant association, and two variants in the locus remained associated with hematuria after conditioning for this variant:\n                      <jats:italic toggle=\"yes\">COL4A3<\/jats:italic>\n                      p.Gly695Arg (rs200287952; minor allele frequency=0.00021;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;2.16E-7; odds ratio, 45.5; 95% confidence interval, 11.8 to 168.0) and a common\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      intron 25 variant (not previously reported; rs58261427; minor allele frequency=0.214;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;2.00E-9; odds ratio, 1.09; 95% confidence interval, 1.06 to 1.12). Of the\n                      <jats:italic toggle=\"yes\">HLA<\/jats:italic>\n                      haplotypes,\n                      <jats:italic toggle=\"yes\">HLA-B<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">*0801<\/jats:italic>\n                      ; minor allele frequency=0.14;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;4.41E-24; odds ratio, 0.84; 95% confidence interval, 0.82 to 0.88) displayed the most statistically significant association. For remaining loci, we identified three novel associations, which were replicated in the deCODE dataset for dipstick hematuria (nearest genes:\n                      <jats:italic toggle=\"yes\">PDPN<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">SORL1<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">PLLP<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our study identifies six loci associated with hematuria, including independent variants in\n                      <jats:italic toggle=\"yes\">COL4A4<\/jats:italic>\n                      -\n                      <jats:italic toggle=\"yes\">COL4A3<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">HLA-B<\/jats:italic>\n                      . Additionally, three novel loci are reported, including an association with an intronic variant in\n                      <jats:italic toggle=\"yes\">PDPN<\/jats:italic>\n                      expressed in the podocyte.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Podcast<\/jats:title>\n                    <jats:p>This article contains a podcast at https:\/\/www.asn-online.org\/media\/podcast\/CJASN\/2022_04_26_CJN13711021.mp3<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.13711021","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T14:36:30Z","timestamp":1651847790000},"page":"672-683","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["GWAS of Hematuria"],"prefix":"10.2215","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1306-1868","authenticated-orcid":false,"given":"Sarah A.","family":"Gagliano Taliun","sequence":"first","affiliation":[{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"},{"name":"Department of Neurosciences, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"},{"name":"Research Centre, Montr\u00e9al Heart Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7123-6123","authenticated-orcid":false,"given":"Patrick","family":"Sulem","sequence":"additional","affiliation":[{"name":"deCODE Genetics\/Amgen, Inc., Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-9468","authenticated-orcid":false,"given":"Gardar","family":"Sveinbjornsson","sequence":"additional","affiliation":[{"name":"deCODE Genetics\/Amgen, Inc., Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-9857","authenticated-orcid":false,"given":"Daniel F.","family":"Gudbjartsson","sequence":"additional","affiliation":[{"name":"deCODE Genetics\/Amgen, Inc., Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1676-864X","authenticated-orcid":false,"given":"Kari","family":"Stefansson","sequence":"additional","affiliation":[{"name":"deCODE Genetics\/Amgen, Inc., Reykjavik, Iceland"},{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-118X","authenticated-orcid":false,"given":"Andrew D.","family":"Paterson","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Dalla Lana School of Public Health, Toronto, Ontario, Canada"},{"name":"Division of Biostatistics, Dalla Lana School of Public Health, Toronto, Ontario, Canada"},{"name":"Genetics and Genome Biology, Research Institute at The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0628-9071","authenticated-orcid":false,"given":"Moumita","family":"Barua","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Nephrology, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Toronto General Hospital Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5]]},"reference":[{"key":"B1-20241015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJMra1604481","article-title":"Hematuria in adults","volume":"385","author":"Ingelfinger","year":"2021","journal-title":"N Engl J Med"},{"key":"B2-20241015","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/hmg\/3.8.1269","article-title":"Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome","volume":"3","author":"Lemmink","year":"1994","journal-title":"Hum Mol Genet"},{"key":"B3-20241015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng0994-77","article-title":"Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome","volume":"8","author":"Mochizuki","year":"1994","journal-title":"Nat Genet"},{"key":"B4-20241015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2215\/CJN.14031119","article-title":"GWAS-based discoveries in IgA nephropathy, membranous nephropathy, and steroid-sensitive nephrotic syndrome","volume":"16","author":"Sanchez-Rodriguez","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20241015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00467-021-04934-y","article-title":"Population-based studies reveal an additive role of type IV collagen variants in hematuria and albuminuria","volume":"37","author":"Barua","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B7-20241015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2215\/CJN.08750718","article-title":"Integration of genetic testing and pathology for the diagnosis of adults with FSGS","volume":"14","author":"Yao","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20241015","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1681\/ASN.2007040444","article-title":"COL4A3\/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy","volume":"18","author":"Voskarides","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B9-20241015","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddy409","article-title":"Sequence variants associating with urinary biomarkers","volume":"28","author":"Benonisdottir","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ajhg.2018.08.004","article-title":"Genetic association of albuminuria with cardiometabolic disease and blood pressure","volume":"103","author":"Haas","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B11-20241015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41588-020-00757-z","article-title":"Genetics of 35 blood and urine biomarkers in the UK Biobank","volume":"53","author":"Sinnott-Armstrong","year":"2021","journal-title":"Nat Genet"},{"key":"B12-20241015","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","article-title":"Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program","volume":"590","author":"Taliun","year":"2021","journal-title":"Nature"},{"key":"B13-20241015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.kint.2018.12.017","article-title":"Identification of 22 novel loci associated with urinary biomarkers of albumin, sodium, and potassium excretion","volume":"95","author":"Zanetti","year":"2019","journal-title":"Kidney Int"},{"key":"B14-20241015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"B15-20241015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet"},{"key":"B16-20241015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"B17-20241015","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/ng.3643","article-title":"A reference panel of 64,976 haplotypes for genotype imputation","volume":"48","author":"McCarthy","year":"2016","journal-title":"Nat Genet"},{"key":"B18-20241015","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1038\/ncomms9111","article-title":"Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel","volume":"6","author":"Huang","year":"2015","journal-title":"Nat Commun"},{"key":"B19-20241015","doi-asserted-by":"crossref","first-page":"e1002877","DOI":"10.1371\/journal.pcbi.1002877","article-title":"Multi-population classical HLA type imputation","volume":"9","author":"Dilthey","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"B20-20241015","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/bioinformatics\/btu197","article-title":"R PheWAS: Data analysis and plotting tools for phenome-wide association studies in the R environment","volume":"30","author":"Carroll","year":"2014","journal-title":"Bioinformatics"},{"key":"B21-20241015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000492427","article-title":"R open source programming code for calculation of the kidney donor profile index and kidney donor risk index","volume":"4","author":"Bikbov","year":"2018","journal-title":"Kidney Dis"},{"key":"B22-20241015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","article-title":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat Genet"},{"key":"B23-20241015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/comjnl\/4.3.265","article-title":"The QR transformation a unitary analogue to the LR transformation - part 1","volume":"4","author":"Francis","year":"1961","journal-title":"Comput J"},{"key":"B24-20241015","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1093\/bioinformatics\/btab186","article-title":"LocusZoom.js: Interactive and embeddable visualization of genetic association study results","volume":"37","author":"Boughton","year":"2021","journal-title":"Bioinformatics"},{"key":"B25-20241015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41588-020-0622-5","article-title":"Exploring and visualizing large-scale genetic associations by using PheWeb","volume":"52","author":"Gagliano Taliun","year":"2020","journal-title":"Nat Genet"},{"key":"B26-20241015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/humu.9065","article-title":"Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome","volume":"20","author":"Dagher","year":"2002","journal-title":"Hum Mutat"},{"key":"B27-20241015","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome","volume":"24","author":"Storey","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B28-20241015","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfv325","article-title":"Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis","volume":"31","author":"Gast","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B29-20241015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ki.2014.305","article-title":"Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis","volume":"86","author":"Malone","year":"2014","journal-title":"Kidney Int"},{"key":"B30-20241015","doi-asserted-by":"crossref","first-page":"22699","DOI":"10.1074\/jbc.M702910200","article-title":"NMR shows hydrophobic interactions replace glycine packing in the triple helix at a natural break in the (Gly-X-Y)n repeat","volume":"282","author":"Li","year":"2007","journal-title":"J Biol Chem"},{"key":"B32-20241015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00441-015-2178-8","article-title":"Alteration in the podoplanin-ezrin-cytoskeleton linkage is an important initiation event of the podocyte injury in puromycin aminonucleoside nephropathy, a mimic of minimal change nephrotic syndrome","volume":"362","author":"Suzuki","year":"2015","journal-title":"Cell Tissue Res"},{"key":"B33-20241015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","year":"2017","journal-title":"Nature"},{"key":"B34-20241015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"B35-20241015","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"B36-20241015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/humu.23364","article-title":"Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome","volume":"39","author":"Daga","year":"2018","journal-title":"Hum Mutat"},{"key":"B37-20241015","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1523-1755.2004.00453.x","article-title":"COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN)","volume":"65","author":"Wang","year":"2004","journal-title":"Kidney Int"},{"key":"B38-20241015","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jaci.2018.11.038","article-title":"HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis","volume":"143","author":"Dand","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B39-20241015","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1681\/ASN.2010010076","article-title":"HLA has strongest association with IgA nephropathy in genome-wide analysis","volume":"21","author":"Feehally","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B40-20241015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng.787","article-title":"Genome-wide association study identifies susceptibility loci for IgA nephropathy","volume":"43","author":"Gharavi","year":"2011","journal-title":"Nat Genet"},{"key":"B41-20241015","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"key":"B42-20241015","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ekir.2020.07.012","article-title":"IgA nephropathy genetic risk score to estimate the prevalence of IgA nephropathy in UK Biobank","volume":"5","author":"Sukcharoen","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B43-20241015","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/s41588-021-00935-7","article-title":"A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response","volume":"53","author":"Luo","year":"2021","journal-title":"Nat Genet"},{"key":"B44-20241015","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1093\/hmg\/ddz243","article-title":"A genome-wide association study implicates multiple mechanisms influencing raised urinary albumin-creatinine ratio","volume":"28","author":"Casanova","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B45-20241015","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMe1911602","article-title":"Realizing the dream of molecularly targeted therapies for cystic fibrosis","volume":"381","author":"Collins","year":"2019","journal-title":"N Engl J Med"},{"key":"B46-20241015","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pmed.1000022","article-title":"STrengthening the REporting of Genetic Association Studies (STREGA): An extension of the STROBE statement","volume":"6","author":"Little","year":"2009","journal-title":"PLoS Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.13711021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:43Z","timestamp":1786369483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.13711021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.13711021","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"2021-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}